Overview
Gestational diabetes mellitus (GDM) is glucose intolerance that is first recognised during pregnancy, arising when maternal insulin secretion cannot meet the increased insulin resistance induced by placental hormones, typically emerging in the second or third trimester. It is one of the most common metabolic complications of pregnancy and is identified through glucose screening and oral glucose tolerance testing. Recognised risk factors include older maternal age, obesity, a family history of diabetes, previous GDM or macrosomia, and certain ethnic backgrounds, and altered inflammatory signalling, including raised proinflammatory cytokines such as IL-6, TNF-alpha, and IL-1beta, has been associated with the condition. Inadequately controlled GDM increases the risk of adverse outcomes for both mother and infant, including macrosomia, operative and caesarean delivery, neonatal hypoglycaemia, pre-eclampsia, and longer-term predisposition to type 2 diabetes in the mother and metabolic risk in the child. Management is structured and stepwise, beginning with medical nutrition therapy and physical activity, with self-monitoring of blood glucose, and adding oral hypoglycaemic agents or insulin when glycaemic targets are not met. Close obstetric surveillance, attention to perioperative care including prevention of surgical-site infection after caesarean section, and postpartum reassessment of glucose status are integral, reflecting the goal of optimising immediate pregnancy outcomes and longer-term maternal and offspring health.
Research published in this journal
6 peer-reviewed articles, ranked by relevance. Each links to its DOI.
Pregnancy Outcome in Gestational Diabetes Mellitus under Treatment-Bangladesh Perspective
The Impact of Nutrients on Diabetes
Association of Gestational Diabetes and Proinflammatory Cytokines (IL-6, TNF-α and IL-1β)
Surgical Site Infection in Cesarean Section Operation: Risk and Management
Trends of Diabetes in Children and Adolescents in Pediatric Endocrinology Clinic and Clinical Pediatric Diabetes Center at Al Baha Central Hospital in Saudi Arabia
How this research is being cited
The 6 articles above have been cited 24 times in the scholarly literature. Citation data via OpenAlex and Crossref, updated Jun 2026.
-
T. Tofail et al. · 2025 · Egyptian Journal of Medical Human Genetics
-
Asma Shaheen et al. · 2025 · Journal of Diabetology
-
2025 · Journal of Diabetology
-
2025 · Egyptian Journal of Medical Human Genetics
-
Aditya Gan et al. · 2024 · Maternal-Fetal Medicine
-
F. Beyene et al. · 2023 · European Journal of Medical Research
-
2023 · European journal of medical research
-
The prevalence of gestational diabetes mellitus in Bangladesh: a systematic review and meta-analysisR. Begum et al. · 2022 · International Journal of Diabetes in Developing Countries
A sample of recent works citing this journal's research on Gestational Diabetes Mellitus, linking to each citing work.